Not Yet Recruiting
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias
NCT07765966
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
- Locations
-
Not specified